Is bone marrow fibrosis the real problem?

Blood

Volumn 107, Issue 9, 2006, Pages 3421-3422

  Hoffman, Ronald ^a   Xu, Mingjiang ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; JANUS KINASE 2;

BONE MARROW; CELL ACTIVATION; CHRONIC DISEASE; DISEASE ASSOCIATION; HEMATOPOIETIC STEM CELL; HUMAN; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; NOTE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROGENY; PULMONARY HYPERTENSION;

EID: 33646398587     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-02-002683     Document Type: Note

References (6)

1. Xu M, Bruno E, Chao J, et al. Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases. Blood. 2005;105:4508-4515.
2. Dingli D, Utz JP, Krowka MJ, Oberg AL, Tefferi A. Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest. 2001;120:801-808.
3. Schermuly RT, Dony E, Ghofrani HA, et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest. 2005;115:2811-2821.
4. Tefferi A, Lasho TL, Gilliland G. JAK2 mutations in myeloproliferative disorders.N Engl J Med. 2005;353:1416-1417.
5. Falanga A, Marchetti M, Evangelista V, et al. Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood. 2000;96:4261-4266.
6. Falanga A, Marchetti M, Vignoli A, Balducci D, Barbui T. Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera. Exp Hematol. 2005;33:523-530.